Special Issue "Vaccines for Infectious and Chronic Diseases"
Deadline for manuscript submissions: closed (31 May 2021).
Interests: vaccines; immunology; autoimmunity; cancer; chronic diseases; exercise; mental health; immunotherapy
Special Issues and Collections in MDPI journals
Special Issue in Cancers: Cancer Vaccines: Research and Applications
Special Issue in Vaccines: Therapeutic Approaches for Type 1 and Type 2 Diabetes
Special Issue in Brain Sciences: Advances in Multiple Sclerosis Research—Series I
Special Issue in Vaccines: Multiple Sclerosis and Its Complications: Clinical Trials
Special Issue in Brain Sciences: Advances in Multiple Sclerosis Research—Series II
Special Issue in International Journal of Molecular Sciences: Complimentary Medicine for the Treatment of Chronic and Infectious Diseases
Special Issue in Biologics: Anti-SARS-CoV-2/COVID-19 Drugs and Vaccines
Special Issue in Vaccines: Multiple Sclerosis, Complications and Therapeutics 2.0
Special Issue in Vaccines: Vaccine Immunology
There is overwhelming scientific consensus that vaccines are a very safe and effective way to fight and eradicate infectious diseases. Vaccination has been a key strategy for the prevention and treatment of numerous pathologies worldwide. The goal of advancement in vaccine formulation is to generate a strong immune response to the administered antigens. To achieve this objective with vaccines based on insufficiently immunogenic antigens, adjuvant and other formulation materials are alternatives. Selection of excipients and adjuvants is a serious task having an implication toward safety, stability, and storage of vaccines. Additionally, novel delivery technologies and systems will be an essential component for next-generation vaccines. A major challenge in vaccine design is identifying antigen presentation and delivery systems capable of rapidly stimulating both the humoral and cellular components of the immune system to elicit a strong and sustained immunity against different pathogens.
This Special Issue focuses on vaccine formulation development for cancer, infectious diseases and chronic diseases. Submission of original articles, systematic reviews, short communications, and other types of article on related topics is welcome. Manuscripts will follow standard Journal peer-review practices, and those accepted for publication will appear in the Special Issue on Vaccines for Infectious and Chronic Dieases. We look forward to receiving and welcome your contributions.Prof. Dr. Vasso Apostolopoulos
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- delivery systems vaccine stability
- infectious diseases